Researchers could not corroborate the beneficial effects of L. brevis CD2 in lowering the rate of grade 3–4 RT–induced OM in patients with HNC, even after considering that the early closure of patient accrual compromised the statistical power of the research. The gene discussed is CD2; the disease is ocular melanoma.